Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-β1

Kidney International

Volumn 63, Issue 3, 2003, Pages 878-888

  Lam, Suzanne ^b   Verhagen, Nicole A M ^b   Strutz, Frank ^b   Van Der Pijl, Johan W ^b   Daha, Mohamed R ^b   Van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Collagen type III; Diabetic nephropathy; Fibroblasts; Fibronectin; Fibrosis; TGF 1

Indexed keywords

ANTIBODY; COLLAGEN TYPE 3; FIBRONECTIN; GLUCOSE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CELL; KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 12244293354     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00824.x     Document Type: Article

References (48)

1. REDDI AS, CAMERINI-DAVALOS RA: Diabetic nephropathy. An update. Arch Intern Med 150:31-43, 1990
2. FIORETTO P, STEFFES MW, BROWN DM, et al: An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics. Am J Kidney Dis 20:549-558, 1992
3. IBRAHIM HN, HOSTEITER TH: Diabetic nephropathy. J Am Soc Nephrol 8:487-493, 1997
4. ZIYADEH FN, GOLDFARB S: The renal tubulointerstitium in diabetes mellitus. Kidney Int 39:464-475, 1991
5. MAUER SM, STEFFES MW, ELLIS EN, et al: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
6. BADER R, BADER H, GRUND KE, et al: Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. Pathol Res Pract 167:204-216, 1980
7. NERLICH A, SCHLEICHER E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889-899, 1991
8. STEFFES MW, BILOUS RW, SUTHERLAND DE, et al: Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41:679-684, 1992
9. VLEMING LJ, BAELDE JJ, WESTENDORP RG, et al: Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 44:211-219, 1995
10. VAN DET NF, VAN DEN BORN J, TAMSMA JT, et al: Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. Kidney Int 49:1079-1089, 1996
11. DANNE T, SPIRO MJ, SPIRO RG: Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes 42:170-177, 1993
12. WAHAB NA, HARPER K, MASON RM: Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem J 316(Pt 3):985-992, 1996
13. STRUTZ F, OKADA H, LO CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
14. ESSAWY M, SOYLEMEZOGLU O, MUCHANETA-KUBARA EC, et al: Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12:43-50, 1997
15. HAN DC, ISONO M, HOFFMAN BB, et al: High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGF-beta. J Am Soc Nephrol 10:1891-1899, 1999
16. JONES SC, SAUNDERS HJ, QI W, et al: Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia 42:1113-1119, 1999
17. BLOBE GC, SCHIEMANN WP, LODISH HF: Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358, 2000
18. SHARMA K, ZIYADEH FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146, 1995
19. VAN DET NF, VERHAGEN NA, TAMSMA JT. et al: Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes 46:834-840, 1997
20. YAMAMOTO T, NAKAMURA T, NOBLE NA, et al: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
21. IWANO M, KUBO A, NISHINO T, et al: Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
22. SHARMA K, JIN Y, GUO J, et al: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
23. VAN VLIET A, BAELDE HJ, VLEMING LJ, et al: Distribution of fibronectin isoforms in human renal disease. J Pathol 193:256-262, 2001
24. TANG WW, ULICH TR, LACEY DE, et al: Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148:1169-1180, 1996
25. EDDY AA, GIACHELLI CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
26. MULLER CA, FRANK J, RODEMANN HP, et al: Human renal fibroblast cell lines (tFKIF and tNKF) are new tools to investigate pathophysiologic mechanisms of renal interstitial fibrosis. Exp Nephrol 3:127-133, 1995
27. LUCAS C, BALD LN, FENDLY BM, et al: The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J Immunol 145:1415-1422, 1990
28. GOUMANS MJ, WARD-VAN OD, WIANNY F, et al: Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo. Differentiation 63:101-113, 1998
29. BURGER A, WAGNER C, VIEDT C, et al: Fibronectin synthesis by human tubular epithelial cells in culture: effects of PDGF and TGF-beta on synthesis and splicing. Kidney Int 54:407-415, 1998
30. STRUTZ F, ZEISBERG M, RENZIEHAUSEN A, et al: TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 59:579-592, 2001
31. OH JH, HA H, YU MR, et al: Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int 54:1872-1878, 1998
32. ZIYADEH FN, SHARMA K; ERICKSEN M, et al: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536-542, 1994
33. LEAL SM, HUANG SS, HUANG JS: Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells. J Biol Chem 274:6711-6717, 1999
34. ITOH S, ITOH F, GOUMANS MJ, et al: Signaling of transforming growth factor-beta family members through smad proteins. Eur J Biochem 267:6954-6967, 2000
35. NAKAO A, AFRAKHTE M, MOREN A, et al: Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389:631-635, 1997
36. LYONS RM, GENTRY LE, PURCHIO AF, et al: Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin: J Cell Biol 110:1361-1367, 1990
37. HUGO C, SHANKLAND SJ, PICHLER RH, et al: Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 53:302-311, 1998
38. JOHNSON DW, SAUNDERS HJ, BAXTER RC, et al: Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 54:747-757, 1998
39. YEVDOKIMOVA N, WAHAB NA, MASON RM: Tbrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 12:703-712, 2001
40. ORPHANIDES C, FINE LG, NORMAN JT: Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 52:637-647, 1997
41. NORMAN JT, CLARK IM, GARCIA PL: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58:2351-2366, 2000
42. CAGLIERO E, ROTH T, TAYLOR AW, et al: The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-beta. Lab Invest 73:667-673, 1995
43. WILSON HM, HAITES NE, BOOTH NA: Effect of angiotensin II on plasminogen activator inhibitor-1 production by cultured human mesangial cells. Nephron 77:197-204, 1997
44. JOHNSON DW, SAUNDERS HJ, JOHNSON FJ, et al: Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: Roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor. J Pharmacol Exp Ther 289:535-542, 1999
45. CLARKSON MR, GUPTA S, MURPHY M, et al: Connective tissue growth factor: a potential stimulus for glomerulosclerosis and tubulointerstitial fibrosis in progressive renal disease. Curr Opin Nephrol Hypertens 8:543-548, 1999
46. ITO Y, ATEN J, BENDE RJ, et al: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861, 1998
47. TWIGG SM, CHEN MM, JOLY AH, et al: Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: A potential mechanism for expansion of extracellular matrix in diabetes mellitus. Endocrinology 142:1760-1769, 2001
48. BLOM IE, VAN DIJK AJ, WIETEN L, et al: In vitro evidence for differential involvement of CTGF, TGF beta, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 16:1139-1148, 2001